Phase III results with a totally implantable piezoelectric middle ear implant: speech audiometry, spatial hearing and psychosocial adjustment.
Zenner HP, Limberger A, Baumann JW, Reischl G, Zalaman IM, Mauz PS, Sweetow RW, Plinkert PK, Zimmermann R, Baumann I, De Maddalena H, Leysieffer H, Maassen MM.
Zenner HP, et al. Among authors: baumann jw, baumann i.
Acta Otolaryngol. 2004 Mar;124(2):155-64. doi: 10.1080/00016480310016055.
Acta Otolaryngol. 2004.
PMID: 15072417
Clinical Trial.